Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Streptococcus uberis is a Gram-positive, environmental pathogen that serves as a leading cause of clinical and subclinical mastitis in dairy cattle worldwide (Leigh, 1999). The whole-cell antigens of S. uberis encompass the entire suite of molecular components—including surface proteins like adhesion proteins (Sua), capsule polysaccharides, and lipoteichoic acids—presented by the inactivated bacterium (Ward et al., 2009). These antigens are primarily targeted in the development of bacterin vaccines, which aim to elicit a robust humoral immune response to prevent bacterial colonization and invasion of the mammary gland (Collado et al., 2018). Upon administration, the host immune system recognizes these diverse epitopes, stimulating the production of antibodies that facilitate opsonization and subsequent clearance by neutrophils (Schukken et al., 2011). This immunological approach is intended to reduce the severity of clinical mastitis and lower the somatic cell count in milk, thereby improving animal welfare and dairy productivity. However, the significant genetic diversity among S. uberis strains remains a major hurdle, as whole-cell antigens from one strain may not provide universal protection against all environmental variants (Leigh, 1999).
Induction of active immunity through the presentation of multiple bacterial epitopes to the host immune system, leading to the production of specific antibodies (IgG1 and IgG2) that enhance opsonization and phagocytic killing of the bacteria by mammary gland neutrophils (Collado et al., 2018; Schukken et al., 2011).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus uberis whole-cell antigens (S. uberis antigens).